Profil bibliographique

Tetsuo Takehara

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

969Publications signalées

23542Citations signalées

7Affiliations récentes

Les institutions déclarées

Osaka Gakuin University Osaka City University Kansai Rosai Hospital Japan Science Society The Physical Society of Japan Japan Organization of Occupational Health and Safety The University of Osaka

Les domaines associés

Hepatitis C virus researchLiver Disease Diagnosis and TreatmentHepatitis B Virus StudiesGastric Cancer Management and OutcomesLiver physiology and pathology

Les publications récentes

Accès ouvert 2026 article OpenAlex

Serum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All‐Cause Mortality After SVR in Advanced Chronic Hepatitis C

Daisuke Sakon, Jumpei Kondo, Yuki Tahata, Hayato Hikita et autres

jp (code pays fourni par la source)

0 citations Hepatology Research

Accès ouvert 2026 article OpenAlex

Serum leucine-rich α-2-glycoprotein and monocyte chemoattractant protein-1 as novel biomarkers for predicting vedolizumab response in patients with ulcerative colitis

Takeo Yoshihara, Shinichiro Shinzaki, Tetsuji Naka, Hideki Iijima et autres

jp (code pays fourni par la source)

0 citations Crohn s & Colitis 360

Accès ouvert 2026 letter OpenAlex

Reply

Seiya Kato, Hayato Hikita, Tetsuo Takehara

jp (code pays fourni par la source)

0 citations Gastroenterology

Accès ouvert 2026 article OpenAlex

Monocyte-derived IL-1β predicts and promotes HBsAg decline in chronic hepatitis B patients under nucleoside analogue therapy

Satoshi Shigeno, Takahiro Kodama, Kazuhiro Murai, Emi Sometani et autres

jp (code pays fourni par la source)

0 citations Hepatology Communications

Accès ouvert 2026 article OpenAlex

Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026

Norio Akuta, Tomomi Kogiso, Kenichi Ikejima, Motoyuki Otsuka et autres

jp (code pays fourni par la source)

0 citations Hepatology Research

2026 article OpenAlex

Nationwide Engagement in an Interdisciplinary eLearning Program on Alcohol Dependence in Japan

Akihiko Shibamoto, Tadashi Namisaki, Ryuhei So, Taro Takami et autres

jp (code pays fourni par la source)

0 citations Hepatology Research

Accès ouvert 2026 article OpenAlex

On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years

Tetsuya Hosaka, Hayato Hikita, Yuki Tahata, Ryoko Yamada et autres

jp (code pays fourni par la source)

0 citations Journal of Gastroenterology

Accès ouvert 2026 article OpenAlex

Impact of Treatment Response to Anticoagulant Therapy on Liver‐Related Events in Patients With Cirrhosis and Portal Vein Thrombosis

Atsushi Maeda, Yuki Tahata, Hayato Hikita, Hisashi Ishida et autres

jp (code pays fourni par la source)

0 citations Hepatology Research

Accès ouvert 2026 article OpenAlex

A combined approach using conventional endoscopy and endoscopic ultrasonography findings yields a highly accurate diagnosis of T2-muscularis propria gastric cancer

Yoshiki Tsujii, Kentaro Nakagawa, Ryotaro Uema, Shunsuke Yoshii et autres

jp (code pays fourni par la source)

1 citation Clinical Endoscopy

Accès ouvert 2025 article OpenAlex

The Nara Declaration: A New Collaborative Flow for Chronic Liver Disease Between Primary Care Physicians and Gastroenterologists/Hepatologists

Takumi Kawaguchi, Hitoshi Yoshiji, Satoshi Mochida, Tetsuo Takehara

jp (code pays fourni par la source)

2 citations Hepatology Research

2025 article OpenAlex

Long-term changes in hepatic reserve and prognosis after direct-acting antiviral treatment in patients with hepatitis C virus-related decompensated cirrhosis: a five-year follow-up study of a Japanese phase 3 trial

Yuki Tahata, Hayato Hikita, Akinobu Takaki, Masayuki Kurosaki et autres

jp (code pays fourni par la source)

2 citations Journal of Gastroenterology

2025 article OpenAlex

Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma

Kazuki Maesaka, Hayato Hikita, Yuki Tahata, Machiko Kai et autres

jp (code pays fourni par la source)

5 citations Journal of Gastroenterology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.